Centogene (CNTG) News Today $0.34 -0.01 (-2.86%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period June 20, 2024 | globenewswire.comC-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug DevelopmentMay 31, 2024 | globenewswire.comCENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General MeetingMay 15, 2024 | globenewswire.comCENTOGENE Reports Full Year 2023 Financial Results and Recent Business HighlightsMay 15, 2024 | globenewswire.comCENTOGENE Secures Approx. $20 Million to Strengthen Cash PositionMay 14, 2024 | globenewswire.comCENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher DiseaseMay 10, 2024 | finanznachrichten.deCentogene NV: CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsMay 10, 2024 | globenewswire.comCENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsApril 4, 2024 | investing.comCentogene faces Nasdaq delisting over share priceApril 2, 2024 | globenewswire.comCENTOGENE Receives Nasdaq Non-Compliance NoticeMarch 22, 2024 | fool.comCentogene (NASDAQ: CNTG)March 19, 2024 | globenewswire.comCENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersMarch 1, 2024 | finanznachrichten.deCentogene NV: CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRa DeficiencyFebruary 29, 2024 | it.investing.comCENTOGENE scopre la carenza del recettore alfa delle cellule pre-TFebruary 29, 2024 | globenewswire.comCENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα DeficiencyFebruary 28, 2024 | finanznachrichten.deCentogene NV: CENTOGENE Explores Strategic AlternativesFebruary 28, 2024 | finanznachrichten.deCentogene NV: CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingFebruary 28, 2024 | markets.businessinsider.comCentogene Explores Strategic Alternatives, Incl. SaleFebruary 28, 2024 | markets.businessinsider.comCentogene Announces Receipt Of Nasdaq Notice Of DelistingFebruary 28, 2024 | msn.comCentogene to explores strategic alternatives, gets Nasdaq delisting notice; shares plungeFebruary 28, 2024 | globenewswire.comCENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingFebruary 28, 2024 | globenewswire.comCENTOGENE Explores Strategic AlternativesJanuary 25, 2024 | finanznachrichten.deCentogene NV: CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationJanuary 25, 2024 | finance.yahoo.comCENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationJanuary 24, 2024 | finanznachrichten.deCentogene NV: CENTOGENE Receives French Research Tax Credit AccreditationJanuary 23, 2024 | finance.yahoo.comCENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using MultiomicsJanuary 18, 2024 | finance.yahoo.comCENTOGENE Announces Preliminary Full Year 2023 RevenueDecember 21, 2023 | morningstar.comCentogene NV Ordinary Shares CNTGDecember 13, 2023 | finanznachrichten.deCentogene NV: CENTOGENE's Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment MilestoneDecember 13, 2023 | msn.comMotus GI, C4 Therapeutics among healthcare moversDecember 13, 2023 | msn.comCCCC, XPOF and AUVI are among pre market gainersDecember 13, 2023 | finance.yahoo.comCENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment MilestoneNovember 28, 2023 | finanznachrichten.deCentogene NV: CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture TransactionNovember 28, 2023 | finance.yahoo.comCENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture TransactionOctober 31, 2023 | msn.comEVER, BIVI and CNTG among mid-day moversSeptember 15, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Centogene NV (CNTG)September 11, 2023 | finance.yahoo.comCENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 7, 2023 | benzinga.comCENTOGENE Reports First Half 2023 Financial ResultsSeptember 1, 2023 | finanznachrichten.deCentogene NV: CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares DeficiencySeptember 1, 2023 | finance.yahoo.comCENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease PatientsAugust 31, 2023 | finance.yahoo.comCENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares DeficiencyAugust 7, 2023 | finance.yahoo.comCENTOGENE to Participate in Upcoming Conferences in AugustJuly 14, 2023 | finanznachrichten.deCentogene NV: CENTOGENE Regains Compliance With Nasdaq Listing RequirementsJuly 12, 2023 | finanznachrichten.deCentogene NV: CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease CohortJuly 12, 2023 | technews.tmcnet.comCENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease CohortJuly 2, 2023 | finance.yahoo.comLifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic TestingJuly 1, 2023 | finanznachrichten.deCentogene NV: CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General MeetingJune 30, 2023 | finance.yahoo.comCENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General MeetingJune 28, 2023 | msn.comHC Wainwright & Co. Reiterates Centogene (CNTG) Buy RecommendationJune 28, 2023 | markets.businessinsider.comAnalyst Expectations for Centogene's FutureJune 27, 2023 | msn.comCNTG Skyrockets after Strategic JV with Lifera Get Centogene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here CNTG Media Mentions By Week CNTG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTG News Sentiment▼1.430.62▲Average Medical News Sentiment CNTG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTG Articles This Week▼20▲CNTG Articles Average Week Get Centogene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MDXH News LH News DGX News NTRA News EXAS News RDNT News GH News FTRE News VCYT News VRDN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTG) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centogene Please log in to your account or sign up in order to add this asset to your watchlist. Share Centogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.